Post-market European & Asian Registry to Evaluate the Minos™ Stent-Graft and Delivery System in Abdominal Aortic Aneurysm Treatment
Key facts
- Who runs it
- Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
- Where
- Brescia, ItalySee the siteAlso in 5 other countries, 15 sites
- Trial code
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 5 Mar 2023
- Expected to end
- 22 Jan 2033
- Type of study
- Observational
- Treatments tested
- Implantation with Minos Stent graft
- Record updated
- 29 June 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Diagnosis of infrarenal abdominal aortic aneurysm
- Plan to treat with Minos Abdominal Aortic Stent-Graft and Delivery System
- Voluntary participation and completion of Informed Consent Form, with willingness to participate in follow-up to 5 years post-procedure
Who cannot take part
- Subjects who are considered not suitable for treatment with stent graft
- Those who are allergic to contrast agents or unable to tolerate contrast agents due to renal insufficiency
- Patients with severe coagulation disorder and/or high risk of postoperative hemorrhage
- Subjects with connective tissue diseases, such as Marfan syndrome
- Subjects who are allergic to nitinol
- Subjects in whom use of the Minos™ Abdominal Aortic Stent-Graft and Delivery System is contraindicated, as follows:
- Severe stenosis or calcification near the aneurysm, leading to difficulty in achieving apposition of vessel wall and stent graft
- Difficult access due to severe stenosis or tortuosity in the iliac artery or femoral artery
- Subjects with ruptured aneurysm or acute aneurysm
- Subjects with an infectious aneurysm
- Aneurysmal neck angulation greater than 60°
- Patients with blood supply to vital organs originating from the aneurysmal sac
- Patients with other comorbidities and whose life expectancy does not exceed one year
- Minors and pregnant women
Where in Italy
Also in 5 other countries, 15 sites
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (ASST Spedali Civili di Brescia)Brescia, ItalyContact: Dipartimento di Chirurgia dell'ASST Spedali Civili di BresciaNot yet recruiting
About the trial
What the trial wants to find out
The Minos™ Abdominal Aortic Stent-Graft and Delivery System is a medical device designed to treat abdominal aortic aneurysms using a minimally invasive procedure. The device is placed inside the aorta through blood vessels, usually accessed through small incisions in the groin. The goal of this observational study is to collect short-, medium- to long-term safety and performance data of the Minos™ stent-graft in everyday medical practice (real-world settings). The aim is to study about 200 patients worldwide and at least 30 patients in European hospitals.
The group in the trial
- PEARL participants
All subjects to be treated with Minos™ Abdominal Aortic Stent-Graft and Delivery System who meet the criteria for inclusion in the PEARL study and voluntarily consent to participate.
Treatment: Implantation with Minos Stent graft
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Prospective Multi-centre Observational Real-world Post-market European & Asian Registry With Low-profile Minos™ Abdominal Aortic Stent Graft
- Record updated
- 29 June 2026